TMEM192 Activators are a diverse group of chemical compounds that enhance the functional activity of TMEM192 through modulation of intracellular signaling pathways. Forskolin, for instance, raises intracellular cAMP levels, which could lead to the activation of protein kinase A (PKA) and subsequent phosphorylation events. These events might enhance TMEM192's role in cellular processes it is associated with. IBMX, by inhibiting phosphodiesterases, also contributes to the elevation of cAMP levels, complementing the cAMP-dependent activation of pathways involving TMEM192. PMA, as an activator of PKC, may phosphorylate substrates that participate in pathways with which TMEM192 interacts, potentially enhancing its activity. Similarly, A23187 by increasing intracellular calcium levels, and sphingosine-1-phosphate, by modulating lipid signaling, could both invoke signaling cascades that indirectly elevate TMEM192 activity. Furthermore, compounds such as Epigallocatechin gallate and LY294002, by inhibiting kinase activities, may reduce competitive signaling and thus might accentuate TMEM192-mediated pathways.
Continuing with the theme of kinase regulation, U0126 and SB203580, which inhibit MEK1/2 and p38 MAPK respectively, could shift the balance of cellular signaling to favor the enhancement of TMEM192's activity. Thapsigargin's role in increasing calcium levels through SERCA inhibition also suggests a potential for boosting TMEM192 activity via calcium-dependent pathways. The inclusion of ZnCl2, which interacts with various signaling pathways, including GPCR signaling,may offer a unique avenue for the indirect activation of TMEM192 through zinc-modulated signaling. Lastly, NMN, by contributing to NAD+ biosynthesis and influencing sirtuin activity, may support the enhancement of TMEM192 activity by modulating cellular metabolism and signaling related to sirtuins. Collectively, these TMEM192 Activators represent a biochemical toolkit that can indirectly foster the enhancement of TMEM192's functional activity within cells, emphasizing the intricate network of signals that converge upon and regulate this protein's role.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased levels of cAMP. Elevated cAMP may enhance the functional activity of TMEM192 by promoting intracellular signaling events that TMEM192 is involved in. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, preventing the breakdown of cAMP and thereby increasing its levels. This can indirectly enhance the functional activity of TMEM192 by modulating signaling pathways that utilize cAMP. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). PKC activation can lead to phosphorylation of proteins and modulation of signaling pathways that TMEM192 is a part of, thus potentially enhancing its activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels, which may activate calcium-dependent signaling pathways that indirectly increase the functional activity of TMEM192. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
Sphingosine-1-phosphate is involved in the activation of signaling pathways that can lead to cellular processes such as autophagy, where TMEM192 may play a role, thus potentially enhancing its functional activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Epigallocatechin gallate is known to inhibit certain types of kinases, which can alter signaling pathways and potentially enhance the functional activity of TMEM192 related to those pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor, which could lead to alterations in the PI3K/AKT signaling pathway, possibly affecting the functional activity of TMEM192 indirectly. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which could shift signaling dynamics in cells, potentially enhancing TMEM192 activity if it is involved in downstream signaling processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that could modulate the MAPK signaling pathway, potentially leading to an enhancement in the functional activity of TMEM192 if it is involved in this pathway. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin raises intracellular calcium levels by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), potentially enhancing TMEM192 activity through calcium-dependent signaling pathways. | ||||||